CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PERSEUS aims to develop a novel cancer therapy using nanotechnology to treat deep-seated, drug-resistant tumors. The therapy utilizes a unique nano-system activated by computed tomography to deliver targeted treatments with minimal side effects, enhancing the effectiveness of cancer care for various tumor types.
PERSEUS intends to implement a novel nanotechnology-based cancer therapy for deep-seated clinically unmanageable, drug-resistant and metastatic tumours.
Practical use of nanotechnology in clinical cancer care is still in its infancy with a full potential yet to be realized.
The therapy is based on a novel nano-system (NS) made of multifunctional 2D layered nanocrystals.
The NS enables, under activation by computed tomography (CT), an effective multimodal therapy with minimal or no adverse effect…
CONSIGLIO NAZIONALE DELLE RICERCHE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Israel, Haifa
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Vigo Pontevedra
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
